{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:51:36Z","timestamp":1787496696820,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ygyno.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T22:00:58Z","timestamp":1559944858000},"page":"368-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Long-term CIN3+ risk of HPV positive women after triage with FAM19A4\/miR124-2 methylation analysis"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5548-4557","authenticated-orcid":false,"given":"St\u00e8fanie","family":"Dick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wieke W.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise M.A.","family":"De Strooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit I.","family":"Lissenberg-Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske D.M.","family":"Steenbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.L.M.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Berkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle A.M.","family":"Heideman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2019.06.002_bb0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"The Lancet Oncology"},{"issue":"3","key":"10.1016\/j.ygyno.2019.06.002_bb0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.ygyno.2019.06.002_bb0015","doi-asserted-by":"crossref","unstructured":"M.G. Dijkstra, M. van Zummeren, L. Rozendaal, F.J. van Kemenade, T.J. Helmerhorst, Snijders PJ, et al. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands. BMJ (Clinical research ed)355, 2016, i4924.","DOI":"10.1136\/bmj.i4924"},{"issue":"Suppl. 5","key":"10.1016\/j.ygyno.2019.06.002_bb0020","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"issue":"9916","key":"10.1016\/j.ygyno.2019.06.002_bb0025","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet (London, England)"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2019.06.002_bb0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human papillomavirus molecular biology and disease association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ygyno.2019.06.002_bb0035","first-page":"354","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","volume":"i3633","author":"Kyrgiou","year":"2016","journal-title":"BMJ (Clinical research ed)"},{"issue":"9","key":"10.1016\/j.ygyno.2019.06.002_bb0040","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14737159.2016.1217157","article-title":"Management of high-risk HPV-positive women for detection of cervical (pre)cancer","volume":"16","author":"Luttmer","year":"2016","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.ygyno.2019.06.002_bb0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ypmed.2018.12.021","article-title":"HPV-based cervical screening: rationale, expectations and future perspectives of the new Dutch screening programme","volume":"119","author":"Polman","year":"2018","journal-title":"Prev. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2019.06.002_bb0050","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76","author":"Wentzensen","year":"2016","journal-title":"Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology."},{"issue":"2","key":"10.1016\/j.ygyno.2019.06.002_bb0055","first-page":"266","article-title":"Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus","volume":"102","author":"Garcia","year":"2003","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2019.06.002_bb0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2008.10.012","article-title":"Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science","volume":"112","author":"Wentzensen","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2019.06.002_bb0065","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrc3728","article-title":"Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions","volume":"14","author":"Steenbergen","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2019.06.002_bb0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1159\/000450595","article-title":"Virtues and weaknesses of DNA methylation as a test for cervical cancer prevention","volume":"60","author":"Lorincz","year":"2016","journal-title":"Acta Cytol."},{"issue":"4","key":"10.1016\/j.ygyno.2019.06.002_bb0075","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ijc.29824","article-title":"Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16\/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study)","volume":"138","author":"Luttmer","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2019.06.002_bb0080","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/bjc.2016.200","article-title":"FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women","volume":"115","author":"Luttmer","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2019.06.002_bb0085","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/1940-6207.CAPR-14-0237","article-title":"Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2\/3 lesions","volume":"7","author":"De Strooper","year":"2014","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"2","key":"10.1016\/j.ygyno.2019.06.002_bb0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ygyno.2016.02.012","article-title":"Validation of the FAM19A4\/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women","volume":"141","author":"De Strooper","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2019.06.002_bb0095","doi-asserted-by":"crossref","first-page":"E579","DOI":"10.1002\/ijc.26496","article-title":"Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection","volume":"131","author":"Bierkens","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2019.06.002_bb0100","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ijc.31539","article-title":"Cervical cancer risk in HPV-positive women after a negative FAM19A4\/mir124-2 methylation test: a post hoc analysis in the POBASCAM trial with 14 year follow-up","volume":"143","author":"De Strooper","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2019.06.002_bb0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20076","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women","volume":"110","author":"Bulkmans","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"9601","key":"10.1016\/j.ygyno.2019.06.002_bb0110","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.ygyno.2019.06.002_bb0115","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jcp.2003.011841","article-title":"The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996","volume":"57","author":"Bulk","year":"2004","journal-title":"J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.06.002_bb0120","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/JCM.40.3.779-787.2002","article-title":"GP5+\/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes","volume":"40","author":"van den Brule","year":"2002","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.ygyno.2019.06.002_bb0125","first-page":"19","article-title":"Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive","volume":"29","author":"Casparie","year":"2007","journal-title":"Cellular oncology : the official journal of the International Society for Cellular Oncology"},{"issue":"9","key":"10.1016\/j.ygyno.2019.06.002_bb0130","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1038\/sj.bjc.6602541","article-title":"Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening","volume":"92","author":"Bulkmans","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"5 Suppl 1","key":"10.1016\/j.ygyno.2019.06.002_bb0135","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/LGT.0b013e318285423c","article-title":"Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines","volume":"17","author":"Katki","year":"2013","journal-title":"Journal of lower genital tract disease"},{"issue":"1","key":"10.1016\/j.ygyno.2019.06.002_bb0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1055-9965.EPI-13-0173","article-title":"Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy","volume":"23","author":"Dijkstra","year":"2014","journal-title":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"3","key":"10.1016\/j.ygyno.2019.06.002_bb0145","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ijc.26056","article-title":"Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening","volume":"130","author":"Rijkaart","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2019.06.002_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1470-2045(14)70019-1","article-title":"Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial","volume":"15","author":"Verhoef","year":"2014","journal-title":"The Lancet Oncology"},{"issue":"14","key":"10.1016\/j.ygyno.2019.06.002_bb0155","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1158\/1078-0432.CCR-16-2641","article-title":"Genome-wide DNA methylation profiling reveals methylation markers associated with 3q gain for detection of cervical precancer and cancer","volume":"23","author":"Verlaat","year":"2017","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"11","key":"10.1016\/j.ygyno.2019.06.002_bb0160","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/ijc.30008","article-title":"Validation of a DNA methylation HPV triage classifier in a screening sample","volume":"138","author":"Lorincz","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2019.06.002_bb0165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13148-017-0419-2","article-title":"Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women","volume":"9","author":"Schmitz","year":"2017","journal-title":"Clin.Epigenetics"},{"key":"10.1016\/j.ygyno.2019.06.002_bb0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13148-016-0196-3","article-title":"Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2\/3","volume":"8","author":"Boers","year":"2016","journal-title":"Clin. Epigenetics"},{"issue":"10","key":"10.1016\/j.ygyno.2019.06.002_bb0175","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/ijc.31976","article-title":"Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial","volume":"144","author":"Cook","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2019.06.002_bb0180","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1158\/1078-0432.CCR-17-3251","article-title":"Human papillomavirus DNA methylation as a biomarker for cervical precancer: consistency across 12 genotypes and potential impact on management of HPV-positive women","volume":"24","author":"Clarke","year":"2018","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"14","key":"10.1016\/j.ygyno.2019.06.002_bb0185","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","article-title":"Phases of biomarker development for early detection of cancer","volume":"93","author":"Pepe","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.ygyno.2019.06.002_bb0190","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/ijc.24774","article-title":"How to evaluate emerging technologies in cervical cancer screening?","volume":"125","author":"Arbyn","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2019.06.002_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22854","article-title":"Intra- and inter-laboratory agreement of the FAM19A4\/mir124-2 methylation test: results from an international study","volume":"33","author":"Floore","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"issue":"10","key":"10.1016\/j.ygyno.2019.06.002_bb0200","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/bjc.2017.309","article-title":"HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test","volume":"117","author":"Polman","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2019.06.002_bb0205","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1158\/1940-6207.CAPR-14-0409","article-title":"Five-year cervical (pre)Cancer risk of women screened by HPV and cytology testing","volume":"8","author":"Uijterwaal","year":"2015","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"2","key":"10.1016\/j.ygyno.2019.06.002_bb0210","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","article-title":"Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial","volume":"20","author":"Polman","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2019.06.002_bb0215","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ (Clinical research ed)"},{"issue":"12","key":"10.1016\/j.ygyno.2019.06.002_bb0220","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.ejca.2011.11.022","article-title":"Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: characteristics of the responders","volume":"48","author":"Gok","year":"2012","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"key":"10.1016\/j.ygyno.2019.06.002_bb0225","doi-asserted-by":"crossref","first-page":"c1040","DOI":"10.1136\/bmj.c1040","article-title":"HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study","volume":"340","author":"Gok","year":"2010","journal-title":"BMJ (Clinical research ed)"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581931279X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581931279X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:43:19Z","timestamp":1758771799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581931279X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S009082581931279X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.06.002","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term CIN3+ risk of HPV positive women after triage with FAM19A4\/miR124-2 methylation analysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}